Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Hide Studies Not Open or Pending
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Condition(s):Non-segmental VitiligoLast Updated:March 27, 2023Completed
Condition(s):VitiligoLast Updated:February 15, 2024Not yet recruiting
Condition(s):Active Non-segmental VitiligoLast Updated:March 25, 2022Completed
Condition(s):VitiligoLast Updated:March 7, 2024Recruiting
Condition(s):Non-segmental VitiligoLast Updated:March 22, 2024Recruiting
Condition(s):Vitiligo; SecukinumabLast Updated:February 10, 2023Completed
Condition(s):VitiligoLast Updated:March 22, 2013Completed
Condition(s):Vitiligo, GeneralizedLast Updated:July 18, 2023Not yet recruiting
Condition(s):VitiligoLast Updated:January 19, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.